297 related articles for article (PubMed ID: 8755541)
21. Abnormal sexual development in transgenic mice chronically expressing müllerian inhibiting substance.
Behringer RR; Cate RL; Froelick GJ; Palmiter RD; Brinster RL
Nature; 1990 May; 345(6271):167-70. PubMed ID: 2336108
[TBL] [Abstract][Full Text] [Related]
22. Extended production of the müllerian duct regressor in the American alligator.
Austin HB
Gen Comp Endocrinol; 1994 Oct; 96(1):122-8. PubMed ID: 7843560
[TBL] [Abstract][Full Text] [Related]
23. Mullerian inhibiting substance ontogeny and its modulation by follicle-stimulating hormone in the rat testes.
Kuroda T; Lee MM; Haqq CM; Powell DM; Manganaro TF; Donahoe PK
Endocrinology; 1990 Oct; 127(4):1825-32. PubMed ID: 2119293
[TBL] [Abstract][Full Text] [Related]
24. [Precocious production of müllerian inhibitor by the fetal rabbit testis].
Koike S; Jost A
C R Seances Acad Sci III; 1982 Dec; 295(12):701-5. PubMed ID: 6820303
[TBL] [Abstract][Full Text] [Related]
25. Endoproteolytic processing of recombinant proalbumin variants by the yeast Kex2 protease.
Ledgerwood EC; George PM; Peach RJ; Brennan SO
Biochem J; 1995 May; 308 ( Pt 1)(Pt 1):321-5. PubMed ID: 7755581
[TBL] [Abstract][Full Text] [Related]
26. Mullerian inhibiting substance: a gonadal hormone with multiple functions.
Lee MM; Donahoe PK
Endocr Rev; 1993 Apr; 14(2):152-64. PubMed ID: 8325249
[TBL] [Abstract][Full Text] [Related]
27. Cellular localization of müllerian inhibiting substance in the developing rat ovary.
Ueno S; Takahashi M; Manganaro TF; Ragin RC; Donahoe PK
Endocrinology; 1989 Feb; 124(2):1000-6. PubMed ID: 2643506
[TBL] [Abstract][Full Text] [Related]
28. Quantification of müllerian inhibiting substance in developing chick gonads by a competitive enzyme-linked immunosorbent assay.
Teng CS
Dev Biol; 1987 Sep; 123(1):255-63. PubMed ID: 3622932
[TBL] [Abstract][Full Text] [Related]
29. Nuclear receptor steroidogenic factor 1 regulates the müllerian inhibiting substance gene: a link to the sex determination cascade.
Shen WH; Moore CC; Ikeda Y; Parker KL; Ingraham HA
Cell; 1994 Jun; 77(5):651-61. PubMed ID: 8205615
[TBL] [Abstract][Full Text] [Related]
30. Molecular basis of mammalian sexual determination: activation of Müllerian inhibiting substance gene expression by SRY.
Haqq CM; King CY; Ukiyama E; Falsafi S; Haqq TN; Donahoe PK; Weiss MA
Science; 1994 Dec; 266(5190):1494-500. PubMed ID: 7985018
[TBL] [Abstract][Full Text] [Related]
31. Identification and functional expression of a new member of the mammalian Kex2-like processing endoprotease family: its striking structural similarity to PACE4.
Nakagawa T; Hosaka M; Torii S; Watanabe T; Murakami K; Nakayama K
J Biochem; 1993 Feb; 113(2):132-5. PubMed ID: 8468318
[TBL] [Abstract][Full Text] [Related]
32. Mullerian duct regression and antiproliferative bioactivities of mullerian inhibiting substance reside in its carboxy-terminal domain.
MacLaughlin DT; Hudson PL; Graciano AL; Kenneally MK; Ragin RC; Manganaro TF; Donahoe PK
Endocrinology; 1992 Jul; 131(1):291-6. PubMed ID: 1612008
[TBL] [Abstract][Full Text] [Related]
33. Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS.
Masiakos PT; MacLaughlin DT; Maheswaran S; Teixeira J; Fuller AF; Shah PC; Kehas DJ; Kenneally MK; Dombkowski DM; Ha TU; Preffer FI; Donahoe PK
Clin Cancer Res; 1999 Nov; 5(11):3488-99. PubMed ID: 10589763
[TBL] [Abstract][Full Text] [Related]
34. Isolation of the rat gene for Mullerian inhibiting substance.
Haqq C; Lee MM; Tizard R; Wysk M; DeMarinis J; Donahoe PK; Cate RL
Genomics; 1992 Apr; 12(4):665-9. PubMed ID: 1572639
[TBL] [Abstract][Full Text] [Related]
35. Involvement of a matrix metalloproteinase in MIS-induced cell death during urogenital development.
Roberts LM; Visser JA; Ingraham HA
Development; 2002 Mar; 129(6):1487-96. PubMed ID: 11880357
[TBL] [Abstract][Full Text] [Related]
36. Mullerian inhibiting substance messenger ribonucleic acid expression in granulosa and Sertoli cells coincides with their mitotic activity.
Hirobe S; He WW; Lee MM; Donahoe PK
Endocrinology; 1992 Aug; 131(2):854-62. PubMed ID: 1639028
[TBL] [Abstract][Full Text] [Related]
37. Proprotein processing activity and cleavage site selectivity of the Kex2-like endoprotease PACE4.
Creemers JW; Groot Kormelink PJ; Roebroek AJ; Nakayama K; Van de Ven WJ
FEBS Lett; 1993 Dec; 336(1):65-9. PubMed ID: 8262218
[TBL] [Abstract][Full Text] [Related]
38. Müllerian inhibiting substance inhibits branching morphogenesis and induces apoptosis in fetal rat lung.
Catlin EA; Tonnu VC; Ebb RG; Pacheco BA; Manganaro TF; Ezzell RM; Donahoe PK; Teixeira J
Endocrinology; 1997 Feb; 138(2):790-6. PubMed ID: 9003016
[TBL] [Abstract][Full Text] [Related]
39. The critical period for mullerian duct regression in the dog embryo.
Meyers-Wallen VN; Manganaro TF; Kuroda T; Concannon PW; MacLaughlin DT; Donahoe PK
Biol Reprod; 1991 Oct; 45(4):626-33. PubMed ID: 1751638
[TBL] [Abstract][Full Text] [Related]
40. Insensitivity of the chick embryo müllerian duct to human recombinant müllerian-inhibiting substance.
Weniger JP; Cate RL; Zeis A
J Mol Endocrinol; 1992 Feb; 8(1):73-7. PubMed ID: 1543536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
